« Return to News | Awards & Advancement

Cyberonics names KenKnight as vice president of emerging therapies

Friday, January 11, 2013 12:33 PM

Cyberonics, a medical technology company with core expertise in neuromodulation, has appointed Bruce H. KenKnight, Ph.D., as vice president of Emerging Therapies.

KenKnight will lead all of the company's emerging therapies programs, including the current clinical evaluation of autonomic regulation therapy, an emerging therapy for treatment of chronic heart failure that incorporates

Most recently, KenKnight served as president and CEO of Valtech Cardio, a privately-held company developing innovative solutions for surgical and percutaneous mitral valve repair and replacement. From 1990-2010, he worked at Boston Scientific, finally serving as vice president of research and business development for the cardiac rhythm management division. He also has served on the board of directors of seven privately-held companies and serves as associate editor for Cardiovascular Engineering and Technology.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.